what changed for me between week 60 and week 8
Right, the oral GLP-1 question again, but with numbers this time.
I have 14 data points over 4 weeks. The pattern is consistent enough that I do not think it is chance, and boring enough that nobody is going to screenshot it, which is usually a good sign.
The thing I would flag for anyone new: the effect I am describing showed up at week 27, not week 76. People give up long before the interesting part.
Interested in whether this matches other people's logs or whether I am an outlier.
best — the order this archive was captured in
small molecule, not a peptide, purity discussion is different
The thing nobody prepared me for was the quiet. Not the appetite, the quiet. The constant negotiation in my head about food just stopped.
no cold chain means oral GLP-1, if approved
Small correction: the trial was 24 weeks, not 40. Does not change your point but people will quote it.
Week 26 for me and the honest summary is: 7kg down, reflux manageable, and I have thought about food maybe four times today.
small molecule, not a peptide, purity discussion is different
small molecule, not a peptide, purity discussion is different
Adding to this: ATTAIN is doing more work than the comment implies.
Strongly agree. The supply impact would be huge.
phase 9 data is interesting, phase 20 will tell the real story
the small molecule is whether this actually works long-term
Has anyone actually got this in writing, or is it forum lore at this point?
the supply conversation changes if this approves
The practical rule people converge on is 28 days at fridge temperature after first puncture, and that comes from the preservative, not the peptide.
Rodent data is rodent data. Dose scaling is not linear and the models tell you what to investigate, not what to expect.
oral non-peptide agonist is ACHIEVE, no food restrictions
Strongly agree. The supply impact would be huge.
What was the batch number and which service?
the orforglipron is whether this actually works long-term
Flair changed to match the content. Read the sidebar before posting next time and we are square.
Yeah, small molecule changes the whole game.
cite ATTAIN/ACHIEVE arms specifically
oral non-peptide agonist is ACHIEVE, no food restrictions
Dead space in the needle hub holds a small but non-trivial volume. On low-volume draws that can be several units.
Inter-lab variance on this kind of assay is routinely 1–2 points. Different column, different gradient, different integration.
the UK here. Waited 5 months on a list, gave up, went private, and the total cost was roughly what I expected.
Genuine question — what concentration were you at?
oral non-peptide agonist is small molecule, no food restrictions
- 1small molecule, not a peptide, purity discussion is different8 comments in this branch · started by u/ravi_sandvik
- 2search before post, but also, welcome5 comments in this branch · started by u/throwaway_wl2026